Equity
CTLT
Catalent Pharma Solutions
Price · Chart
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CTLT to draw a line in its place.
The chart above plots the price of CTLT over the range selected — one day to the full history — drawn by TradingView from their own data.
Filings 2 sets
CTLT institutional holders
0 of the 45 institutional funds we track reported a CTLT position for the quarter ended 31 Dec 2024; the latest of those filings landed 28 Apr 2025.
Fund
Action
Shares
Value
Source: SEC EDGAR 13F filings
Congressional trades in CTLT
The most recent congressional trade disclosed in CTLT is a purchase by Daniel S. Goldman (house, NY), dated 07 Mar 2023.
Date
Member
Type
Amount
07 Mar 2023
filed 17 Apr 2023
Daniel S. Goldman
house · Democrat–NY
Purchase
$1K–$15K
30 Nov 2022
filed 29 Dec 2022
Susie Lee
house · Democrat–NV
Sale
$1K–$15K
18 Dec 2020
filed 23 Sep 2021
Thomas R. Suozzi
house · Democrat–NY
Purchase
$1K–$15K
29 Sep 2020
filed 14 Oct 2020
Gilbert Ray Cisneros, Jr.
house · Democrat–CA
Sale
$1K–$15K
24 Sep 2020
filed 13 Oct 2020
Josh Gottheimer
house · Democrat–NJ
Sale
$1K–$15K
17 Aug 2020
filed 14 Sep 2020
Gilbert Ray Cisneros, Jr.
house · Democrat–CA
Sale
$1K–$15K
12 Aug 2020
filed 20 Sep 2020
Josh Gottheimer
house · Democrat–NJ
Sale
$1K–$15K
19 Jun 2020
filed 17 Jul 2020
Gilbert Ray Cisneros, Jr.
house · Democrat–CA
Sale
$1K–$15K
Source: U.S. House of Representatives financial disclosures